Pomerantz receives American Cancer Society grant

Professor William Pomerantz and his researchers have been awarded an American Cancer Society Institutional Research Grant to support their research designing a class of peptide mimetic, which they term polarity switch peptides. Molecular design rules are being developed as a general approach for inhibiting transcription factor-protein interactions involved in acute myeloid leukemia. In-cell ¹⁹F nuclear magnetic resonance methods are also being investigated to quantitate cellular uptake of these compounds. This one-year award will cover research expenditures, starting July 1.